In PDAC, high CD73 expression is associated with an immunosuppressive TME, decreased survival rates, and reduced levels of CD4+, CD8+, and CD21+ tumor-infiltrating lymphocytes (TILs) [202]. This evidence concerns the gene CD8A and neoplasm.